301246 宏源药业
2026/03 - 三个月2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)3.1842.7001.1802.69322.933
总资产报酬率 ROA (%)2.3191.9860.8971.83013.786
投入资产回报率 ROIC (%)2.6052.2631.0122.14417.436

边际利润分析
销售毛利率 (%)32.00218.77612.18512.98723.324
营业利润率 (%)26.1018.1603.3915.14123.256
息税前利润/营业总收入 (%)23.9388.0413.2034.63122.630
净利润/营业总收入 (%)20.4966.0652.9064.24221.069

收益指标分析
经营活动净收益/利润总额(%)96.84299.20197.24290.91266.078
价值变动净收益/利润总额(%)15.00222.58811.51022.60635.567
营业外收支净额/利润总额(%)-11.380-8.614-0.593-7.190-0.410

偿债能力分析
流动比率 (X)2.8842.6562.6823.5001.261
速动比率 (X)2.5952.3992.4443.2910.994
资产负债率 (%)26.67027.67125.13022.84545.453
带息债务/全部投入资本 (%)17.13615.75412.84311.75428.092
股东权益/带息债务 (%)474.014523.450663.789733.974244.423
股东权益/负债合计 (%)275.000261.437297.906337.728120.007
利息保障倍数 (X)47.51415.231-19.111-28.042-42.601

营运能力分析
应收账款周转天数 (天)66.73163.66345.43945.92839.143
存货周转天数 (天)61.51167.36253.48554.81083.884